Genertec Universal Medical Group Company Limited Cash Flow-to-Debt Ratio
Genertec Universal Medical Group Company Limited cash flow-to-debt ratio. Genertec Universal Medical Group Company Limited (5UM) has a Cash Flow-to-Debt Ratio of -0.03x as of June 2023, meaning its operating cash flow of €-1.67 Billion could theoretically repay 0% of its total liabilities (€64.56 Billion) in one year. Check 5UM cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Genertec Universal Medical Group Company Limited (2016–2025)
Cash flow-to-debt ratio of Genertec Universal Medical Group Company Limited from 2016 to 2025. Historical debt coverage capacity for Genertec Universal Medical Group Company Limited across 10 annual periods. Check 5UM capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Genertec Universal Medical Group Company Limited Cash Flow-to-Debt Ratio by Year (2016–2025)
Genertec Universal Medical Group Company Limited cash flow-to-debt ratio by year from 2016 to 2025. Year-by-year debt coverage analysis for Genertec Universal Medical Group Company Limited. For the full cash flow conversion analysis, see Genertec Universal Medical Group Company (5UM) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | €5.78 Billion | €59.28 Billion | ▲ +440.7% |
| 2024 | 0.02x | €1.14 Billion | €63.16 Billion | ▼ -78.4% |
| 2023 | 0.08x | €4.99 Billion | €59.98 Billion | ▲ +131.4% |
| 2022 | 0.04x | €2.06 Billion | €57.17 Billion | ▲ +234.3% |
| 2021 | -0.03x | €-1.40 Billion | €52.28 Billion | ▼ -28.3% |
| 2020 | -0.02x | €-971.72 Million | €46.55 Billion | ▲ +49.2% |
| 2019 | -0.04x | €-1.82 Billion | €44.41 Billion | ▲ +73.5% |
| 2018 | -0.15x | €-5.73 Billion | €37.00 Billion | ▲ +7.6% |
| 2017 | -0.17x | €-5.07 Billion | €30.26 Billion | ▼ -57.6% |
| 2016 | -0.11x | €-2.38 Billion | €22.39 Billion | — |